Company Filing History:
2 out of 915 
2 out of 1,289 
Years Active: 2022-2024
Title: Marion Curtis: Innovator in Cancer Treatment
Introduction
Marion Curtis is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of cancer treatment, particularly through her innovative approaches to immunotherapy. With a total of 2 patents, her work focuses on targeted therapies that aim to improve outcomes for patients suffering from ovarian cancer.
Latest Patents
Marion Curtis's latest patents include methods of treating cancers with CT45 targeted therapies. The current disclosure relates to methods for treating ovarian cancer based on specific antigen expression of the cancer. Furthermore, the expressed antigen may be used in immunotherapeutic methods for the treatment of ovarian cancer. Aspects of the disclosure relate to immunotherapies targeting CT45 polypeptides, methods for treating ovarian cancer based on CT45 expression, and kits for detecting CT45 polypeptides and nucleotides.
Career Highlights
Throughout her career, Marion has worked with esteemed institutions such as the University of Chicago and the Max Planck Society for the Advancement of Science. Her research has been pivotal in advancing the understanding and treatment of ovarian cancer, showcasing her dedication to improving patient care.
Collaborations
Some of her notable coworkers include Ernst Lengyel and Matthias Mann. Their collaborative efforts have contributed to the development of innovative cancer therapies and have furthered research in the field.
Conclusion
Marion Curtis stands out as a leading inventor in the realm of cancer treatment, with her groundbreaking patents and collaborations paving the way for future advancements. Her work continues to inspire and impact the medical community, particularly in the fight against ovarian cancer.